Boston Scientific (BSX) Net Cash Flow Growth (5y) (2014 - 2026)
Boston Scientific (BSX) Net Cash Flow Growth (5y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -31.52% |
| Dec 31, 2025 | 33.75% |
| Sep 30, 2025 | 22.70% |
| Jun 30, 2025 | -16.40% |
| Mar 31, 2025 | 21.61% |
| Dec 31, 2024 | -90.53% |
| Sep 30, 2024 | 27.90% |
| Jun 30, 2024 | 58.05% |
| Mar 31, 2024 | -6.87% |
| Dec 31, 2023 | 11.71% |
| Sep 30, 2023 | 121.82% |
| Jun 30, 2023 | 3.72% |
| Mar 31, 2023 | -34.61% |
| Dec 31, 2022 | 13.83% |
| Sep 30, 2022 | -26.26% |
| Jun 30, 2022 | -19.53% |
| Mar 31, 2022 | -58.84% |
| Dec 31, 2021 | -44.57% |
| Sep 30, 2021 | -29.51% |
| Jun 30, 2021 | 44.61% |